ARTICLE | Clinical News
PolyHeme: Phase III ongoing
July 26, 2004 7:00 AM UTC
An independent data monitoring committee (IDMC) recommended continuation of a Phase III trial of PolyHeme in up to 720 severely injured and bleeding trauma patients. The trial has an SPA. ...